Global Perspectives on Melanoma, Squamous Cell Carcinoma (SCC), and Basal Cell Carcinoma (BCC)
June 26, 2021
Faculty Chair
Jeffrey S. Weber, MD, PhD
NYU Langone Medical Center, New York, NY, USA
Faculty Members
Omid Hamid, MD
Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA
Adi Diab, MD
MD Anderson Cancer Center, Houston, TX, USA
Alexander Eggermont, MD, PhD
Princess Máxima, Utrecht, the Netherlands
Ragini Kudchadkar, MD
Emory University, Atlanta, GA, USA
Hussein Tawbi, MD, PhD
MD Anderson Cancer Center, Houston, TX, USA
KEY TAKEAWAYS AND STRATEGIC INSIGHTS
- New perspectives in melanoma adjuvant and neoadjuvant therapy
- Emerging insights in relapsed/refractory metastatic melanoma
- Evolution of immunotherapy for 1L metastatic melanoma
- 1L BRAF-mutated metastatic melanoma –Strategies to improve on MAPK-targeted therapies
- Emerging advances in the management of BCC
